Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro

Because rare, but severe adverse effects, i.e. retinal vasculitis or retinal vein occlusion, have been observed after repetitive intravitreal injections of VEGF-A-binding single-chain variable fragment brolucizumab (Beovu), we investigated its possible impact on the barrier formed by immortalized bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Deissler, Heidrun L., Busch, Catharina, Wolf, Armin, Rehak, Matus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304347/
https://www.ncbi.nlm.nih.gov/pubmed/35864147
http://dx.doi.org/10.1038/s41598-022-16770-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304347/
https://www.ncbi.nlm.nih.gov/pubmed/35864147
http://dx.doi.org/10.1038/s41598-022-16770-7

Ejemplares similares